You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 4, 2024

~ Buy the ODOMZO (sonidegib phosphate) Drug Profile, 2024 PDF Report in the Report Store ~

CLINICAL TRIALS PROFILE FOR ODOMZO

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for ODOMZO

Subscribe to access the full database, or Sign Up
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT02086552 ↗	Sonidegib and Lenalidomide After Stem Cell Transplant in Treating Patients With Multiple Myeloma	Active, not recruiting	National Cancer Institute (NCI)	Phase 2	2014-01-17	This phase II trial studies how well sonidegib and lenalidomide after stem cell transplant works in treating patients with multiple myeloma. Sonidegib and lenalidomide may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth and may delay multiple myeloma from coming back after a stem cell transplant.
NCT02086552 ↗	Sonidegib and Lenalidomide After Stem Cell Transplant in Treating Patients With Multiple Myeloma	Active, not recruiting	Novartis Pharmaceuticals	Phase 2	2014-01-17	This phase II trial studies how well sonidegib and lenalidomide after stem cell transplant works in treating patients with multiple myeloma. Sonidegib and lenalidomide may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth and may delay multiple myeloma from coming back after a stem cell transplant.
NCT02086552 ↗	Sonidegib and Lenalidomide After Stem Cell Transplant in Treating Patients With Multiple Myeloma	Active, not recruiting	Mayo Clinic	Phase 2	2014-01-17	This phase II trial studies how well sonidegib and lenalidomide after stem cell transplant works in treating patients with multiple myeloma. Sonidegib and lenalidomide may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth and may delay multiple myeloma from coming back after a stem cell transplant.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for ODOMZO

Condition Name

Chart
Table

Condition Name for ODOMZO
Intervention	Trials
Stage IV Lung Cancer AJCC v8	1
Basal Cell Nevus Syndrome	1
Pathologic Stage III Gastric Cancer AJCC v8	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for ODOMZO
Intervention	Trials
Carcinoma	4
Skin Neoplasms	3
Carcinoma, Basal Cell	3
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for ODOMZO

Trials by Country

Map
Table

Trials by Country for ODOMZO
Location	Trials
United States	6
Australia	1
Italy	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for ODOMZO
Location	Trials
Minnesota	3
Florida	1
Arizona	1
California	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for ODOMZO

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for ODOMZO
Clinical Trial Phase	Trials
Phase 2	4
Phase 1	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for ODOMZO
Clinical Trial Phase	Trials
Recruiting	3
Active, not recruiting	1
Completed	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for ODOMZO

Sponsor Name

Chart
Table

Sponsor Name for ODOMZO
Sponsor	Trials
National Cancer Institute (NCI)	4
Mayo Clinic	3
Novartis Pharmaceuticals	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for ODOMZO
Sponsor	Trials
Other	6
NIH	4
Industry	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.